🇺🇸 FDA
Patent

US 7332470

Methods and compositions for treating ocular disease

granted A61KA61K38/39A61P

Quick answer

US patent 7332470 (Methods and compositions for treating ocular disease) held by The Regents of the University of California expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/39, A61P, A61P27/02, A61P27/04